Riskpilot← Back to searchSign inGet full accessBonum Medicum AB
ABActiveOrg 5569854655Nehrmans Väg 24Medical specialists activities · NACE 8622Est. 20142 employees
Revenue 2025
SEK 3,6M
+24% vs 2024
EBITDA margin
53.5%
+142% vs 2024
Equity ratio
23.3%
Financial strength
Net profit 2025
SEK 783K
+1051% vs 2024
| Revenue | SEK 3,6M | +24% |
| EBITDA | SEK 1,9M | +142% |
| Net profit | SEK 783K | +1051% |
| Total assets | SEK 3,6M | +17% |
| Equity | SEK 833K | +495% |
| Employees | 2 | — |
Legal name
Bonum Medicum AB
Org number
5569854655
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 oktober 2014
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget skall erbjuda medicinsk konsultverksamhet.
Address
Nehrmans Väg 24
Email
olof.rask@med.lu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 82 | 79 | 551 | 2 861 | 3 557 |
| Staff expenses | — | −0 | −117 | — | — |
| EBITDA | −35 | −24 | 336 | 787 | 1 903 |
| Depreciation & amort. | −0 | — | −275 | −400 | −400 |
| EBIT | −35 | −24 | 61 | 387 | 1 503 |
| Net financials | −1 | −1 | −54 | −144 | −191 |
| Profit before tax | −12 | −25 | 6 | 87 | 987 |
| Tax | −0 | — | — | −19 | −204 |
| Net profit | −12 | −25 | 6 | 68 | 783 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 131 | 103 | 2 396 | 3 068 | 3 578 |
| Equity | 92 | 66 | 73 | 140 | 833 |
| Long-term debt | 0 | — | 2 305 | 2 198 | 2 024 |
| Short-term debt | 39 | 36 | 18 | 573 | 364 |
| Total debt | 39 | 36 | 2 323 | 2 771 | 2 388 |
EBITDA margin
53.5%
This company
15.8%
Market median
+239% vs market
20212025
Equity ratio
23.3%
This company
38.2%
Market median
-39% vs market
20212025
Return on equity
94.0%
This company
18.4%
Market median
+411% vs market
20212025
Net profit margin
22.0%
This company
8.1%
Market median
+172% vs market
20212025
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20212025
Debt / equity
3.30×
This company
0.62×
Market median
-432% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LO Chief Executive Officer | Chief Executive Officer | 2022 |
EH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Former (1) | ||
LL Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bonum Medicum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Olof Gunnar Rask | Chief Executive Officer | 0 companies |
| Emma Hedvig Charlotta Adlercreutz | Deputy Chief Executive Officer | 0 companies |
| Lars Ludvigh Stensson Nyström | Chief Executive Officer | 0 companies |